Trial results for a community support program aimed at improving adherence to lung cancer screening in West Philadelphia were posted on 2026-03-24, indicating that 21 participants in the West Philadelphia CSP group attended their scheduled appointments.
Background
Lung cancer remains a leading cause of cancer-related mortality, and early detection through screening is crucial for improving patient outcomes. However, adherence to lung cancer screening (LCS) follow-up guidelines, particularly in urban environments, can be challenging due to various barriers. Community support programs (CSPs) aim to address these barriers by providing practical assistance, such as transportation coordination, to help individuals attend their scheduled screenings. This specific project focused on West Philadelphia residents within the Penn Medicine healthcare system to enhance adherence to LCS follow-up guidelines.
Trial design
This completed study, identified as Phase NA, enrolled 252 participants with Lung Cancer. The trial investigated the impact of a community support program (CSP) designed to improve adherence to lung cancer screening follow-up guidelines. The program targeted individuals in the Penn Medicine healthcare system residing in Philadelphia who had upcoming or missed follow-up screenings or orders placed but not yet scheduled. The CSP offered free transportation coordination to and from appointments and aimed to connect participants with additional support. While specific primary outcomes were not listed, the study collected data on attended screening appointments across different participant groups.
Key results
The trial results focused on the number of scheduled lung cancer screening appointments attended by participants across different groups, as well as the enrollment in the Community Support Program (CSP):
- Among West Philadelphia CSP Participants, 21 individuals attended their scheduled lung cancer screening appointments.
- For West Philadelphia Non CSP Participants, 65 individuals attended their scheduled lung cancer screening appointments.
- In the Southwest Philadelphia Residents group, 59 individuals attended their scheduled lung cancer screening appointments.
- The total CSP Enrollment for West Philadelphia Residents was 34 participants.
What this means
The posted results provide specific attendance figures for lung cancer screening appointments across different community groups. For the West Philadelphia CSP Participants, 21 individuals attended their scheduled screenings. This figure can be contextualized against 65 attendees among West Philadelphia Non CSP Participants and 59 attendees among Southwest Philadelphia Residents. Additionally, the study reported a total CSP Enrollment of 34 participants for West Philadelphia Residents. These data points offer insights into screening adherence within the studied urban population and the reach of the community support program.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT06628167, titled "Community Support Program for Lung Cancer Screening Volume II", were posted on 2026-03-24 on clinicaltrials.gov.